Elvin Lee and Jerald Hammann Call for Board Overhaul at Salarius Pharmaceuticals (SLRX) Amid Mismanagement Concerns

Key Summary: Elvin Lee and Jerald Hammann criticized Salarius Pharma's board for mismanagement and called for overhaul.

Market Cap: $2 million | Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need.  

Background

On October 27, 2023, Elvin Sanghwan Lee,  an Individual In…